Matthias Salathe, MD
Enriched profileChair, Department of Internal Medicine; Professor of Pulmonary, Critical Care and Sleep Medicine · University of Kansas Medical Center
Matthias Salathe is Chair, Department of Internal Medicine; Professor of Pulmonary, Critical Care and Sleep Medicine at University of Kansas Medical Center. OpenAlex indexes 254 publications with 9,201 citations (h-index 51); ClinicalTrials.gov lists 7 registered studies with this person as an investigator.
Data verified 8 Oct 2026
Overview
Updated 16 Oct 2026
Matthias Salathe, MD, is Chair, Department of Internal Medicine at University of Kansas Medical Center. The public record shows 254 publications with 9,201 citations (h-index 51), centered on Cystic Fibrosis Research Advances, Chronic Obstructive Pulmonary Disease (COPD) Research, Asthma and respiratory diseases. It also documents an investigator role on 7 registered clinical trials, industry payments reported by 1 companies, 5 NIH-funded awards (2018–2026).
- Most recent indexed publication: 2026 · Nature medicine
- Top research focus: Cystic Fibrosis Research Advances
- 7 registered trials on ClinicalTrials.gov
- Open Payments reporting from 1 companies
Generated from the cited public record · current as of 16 Oct 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintDrugs & molecules
across trials, industry payments and publicationsWorks with
trial sponsors and companies reporting paymentsScholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID; 23 in PubMed.
Total citations across indexed works.
Hirsch index (OpenAlex). i10-index 129.
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Clinical trials
Updated 16 Oct 2026
Listed as an investigator on 7 registered studies on ClinicalTrials.gov. The most recent:
- Targeting Inflammation With Losartan to Improve Response to Modulator Therapy in Cystic Fibrosis.
Sponsor: University of Kansas Medical Center
- Metformin for People With CFRD on CFTR Modulator Therapy to Improve Ion Channel Function
Sponsor: University of Kansas Medical Center
- Study of Open Label Losartan in COVID-19
Sponsor: University of Kansas Medical Center
Industry payments
Updated 16 Oct 2026
1 company reported payments to CMS in program years 2025–2025. These are public disclosures, not judgments. The latest:
- Insmed, Inc.Program year20251 payment
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Respiratory
72.1%Other respiratory system products72.1%Trikafta100%Part D<11 patientsMetabolism & gastrointestinal
27.9%Antidiarrheal microorganisms27.9%Creon100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
Updated 16 Oct 2026
5 NIH research awards on record, funded 2018–2026 per NIH RePORTER. The latest:
- All of Us Research Program Heartland Consortium (AoURP-HC)
University of Kansas Medical Center
FY2026$1,735,000OT2OD036430 - Targeting airway BK channels for first in class, mutation agnostic treatment of mucus plugging in cystic fibrosis
University of Kansas Medical Center
FY2026$426,250R21HL185889 - All of Us Research Program Heartland Consortium (AoURP-HC)
University of Kansas Medical Center
FY2025$1,500,000OT2OD036430
Publications
Updated 16 Oct 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
- Inhaled siRNA therapy targeting RAGE for pulmonary inflammation: a first-in-human randomized trial.
Nature medicine
Clinical Trial2026 - Differentiating between BK activation and potentiation by vanzacaftor enantiomers.
American journal of physiology. Cell physiology
Letter2026 - Therapeutic strategies to reverse cigarette smoke-induced ion channel and mucociliary dysfunction in COPD airway epithelial cells.
American journal of physiology. Lung cellular and molecular physiology
Article2025 - Short-lived reactive components substantially contribute to particulate matter oxidative potential.
Science advances
Article2025 - Impact of Hydrophobic, Hydrophilic, and Mucus-Binding Motifs on the Therapeutic Potential of Ceftazidime Analogs for Pulmonary Administration.
Antibiotics (Basel, Switzerland)
Article2025
Most-cited works
by citation count (OpenAlex)- 01Mucociliary Clearance in the AirwaysArticle749 citations1996
- 02Adult Patients With BronchiectasisArticle441 citations2016
- 03Regulation of Mammalian Ciliary BeatingReview406 citations2006
- 04
- 05
Network
Updated 16 Oct 2026
The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.
Online presence
Updated 16 Oct 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Owned accounts
public accounts run by this person- Doximity
doximity.com/pub/matthias-salathe-md
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Background & recognition
Updated 16 Oct 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Education
degrees and training on record- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →findadoctor.kansashealthsystem.com ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →findadoctor.kansashealthsystem.com ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →findadoctor.kansashealthsystem.com ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →findadoctor.kansashealthsystem.com ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
Mario Castro, MD
University of Kansas Medical Center
Jeffrey Burns, MD
University of Kansas Medical Center
Mazen Dimachkie, MD
University of Kansas Medical Center
Carol Fabian, MD
University of Kansas Medical Center
Fernando Martinez, MD
University of Massachusetts Chan Medical School
David Gozal, MD
Marshall University
Ronald Crystal, MD
Weill Cornell Medicine
Bartolome Celli, MD
Brigham and Women's Hospital